Viral hepatitis Hepatitis A, B, D, and E (HAV, HBV, HDV, HEV respectively). Herpes Simplex virus Hepatitis Epstein Barr virus Hepatitis Yellow fever Q fever Drug toxicity Acetaminiphen Halothane Isoniazid…
Fig. 26.1 Cumulative proportion of patients transitioning from a compensated to a decompensated stage. Data from D’Amico et al. [83] Fig. 26.2 Cumulative risk of complications from cirrhosis over time….
Generic name (brand name) FDA approved for induction Dose Common adverse effects Rabbit antithymocyte globulin (Thymoglobulin®) No 1.5 mg/kg IV 3–5 doses. Infused over 6 h if central line or…
Fig. 37.1 Simulation course timeline . Timeline showing simulation course components. Physical resources are color-coded. Pre-class material is viewed on the website which occurs before the day that the simulation…
Fig. 27.1 Anterior view of the liver. IVC inferior vena cava, PHA proper hepatic artery, MPV main portal vein, CBD common bile duct Fig. 27.2 Posterior view of the liver….
Fig. 25.1 The first baboon-to-human liver xenotransplantation recipient painted by Sir Roy Calne (with the generous permission of Sir Roy Calne) Proliferation Stage In the following 16 years, liver transplantation…
Stage Description Stage A At high risk for HF, but without evidence of structural heart disease Stage B Evidence of structural heart disease, but without signs or symptoms of HF…
Patients Cirrhotics without cardiomyopathy Cirrhotics with cardiomyopathy At rest • Clinical findings: Hyperdynamic state (few patients) • Echocardiography: 1. Prolonged isovolumetric relaxation time (mild) • Electrocardiogram: QT prolongation (few patients) •…
Blood glucose level (g/dL) Regular insulin infusion rate (U/h) D5W infusion rate (mL/h) >350 3–5a 0 250–350 3a 0 150–250 2a 0 100–150 2 20 70–100 1–2 20–100 <70 0…
Fig. 5.1 Pathophysiologic changes during brain death. BBB blood brain barrier, DI diabetes insipidus, DIC disseminated intravascular coagulopathy, ICP intracranial pressure First Phase: Peri-Death Just prior to the development of…
